Bengaluru-based health diagnostic company Acculi Labs raises Rs 5 crore (about $700,000) in a seed funding round from PirE Ventures, an investment firm based out of Mumbai.
Acculi Labs was founded in May 2017 by Rupam Das. Acculi Labs aims to make home-based care available to the last person at the bottom of the pyramid. Its flagship product, Lyfas, enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients even in the remotest part of the world and helps them to approach their doctor at an early stage.
Rupam Das, the CTO and CEO of Acculi Labs, said, “The investment will be used to bring our vision to reality. [Our] R&D will work with new vigour and rigour to simplify healthcare for the needy. [We] will run full business operations to ensure that Lyfas becomes the need of every household, irrespective of geophysical location, as we at Acculi believe that healthcare is the need of people.”
Geetha Mahadevappa, PirE Ventures, said, “We see a lot of potential in Lyfas to transform the way we diagnose and monitor diseases today. The asset-light and tech-driven models of the company are easily pluggable into various setups, including OPD, telemedicine, and post-surgery care. We believe that together PirE and Acculi can redefine digital health not only for people, but for the nation”.
According to the startup, the challenge of bringing such a product to the market is – it needs to clear several stages of clinical validation, compliances, and certification which are both time and cost intensive.